Physician
Kazi Ophthalmology
Kazi Ophthalmology was paid $298K by Medicaid between Jan 2018 and Nov 2024, across 29 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 15% of everything it billed.
33Billing provider infoKAZI OPHTHALMOLOGY
ANNISTON, AL 36207
ANNISTON, AL 36207
33aNPI1205136868assigned 10/29/2010
33bProvider typeOphthalmology Physician
28Total paid$298K
24GClaims15,572
24DCodes billed29
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ophthalmology Physician providers in Alabama
Rank by total paid#7 of 51
Median peer was paid$22K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,135 | $24K | |
| 2019 | 2,978 | $38K | |
| 2020 | 1,536 | $25K | |
| 2021 | 1,296 | $28K | |
| 2022 | 2,179 | $52K | |
| 2023 | 2,829 | $77K | |
| 2024incomplete | 2,619 | $54K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 15% | 895 | 580 | $45K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 1,730 | 1,279 | $41K |
| V2745 | Addition to lens; tint, any color, solid, gradient or equal, excludes photochromatic, any lens material, per lens | 12% | 406 | 358 | $36K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.3% | 1,584 | 1,198 | $28K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 7.3% | 1,508 | 1,345 | $22K |
| V2020 | Frames, purchases | 5.9% | 1,521 | 1,355 | $18K |
| V2750 | Anti-reflective coating, per lens | 4.9% | 262 | 239 | $15K |
| V2499 | Variable sphericity lens, other type | 4.7% | 329 | 279 | $14K |
| V2784 | Lens, polycarbonate or equal, any index, per lens | 4.4% | 840 | 744 | $13K |
| 92250 | 4.4% | 652 | 539 | $13K | |
| J9035 | Injection, bevacizumab, 10 mg | 3.7% | 424 | 295 | $11K |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 3.4% | 864 | 760 | $10K |
17 more codes
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2.8% | 152 | $8K |
| 92015 | Determination of refractive state | 2.5% | 1,148 | $8K |
| 92134 | 2.3% | 908 | $7K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 33 | $2K |
| 92226 | <1% | 405 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 42 | $2K |
| V2755 | U-v lens, per lens | <1% | 419 | $1K |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 52 | $1K |
| 65800 | <1% | 40 | $519.80 | |
| 92202 | <1% | 123 | $426.60 | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 45 | $361.52 |
| 92083 | <1% | 13 | $322.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 478 | $0.00 |
| 2022F | 0% | 97 | $0.00 | |
| G8421 | Bmi not documented and no reason is given | 0% | 506 | $0.00 |
| V2760 | Scratch resistant coating, per lens | 0% | 81 | $0.00 |
| 99027 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKAZI, ABDUL (PRESIDENT)